価格表

在庫・価格 : 2024年05月02日 14時57分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
CTLA-4/Fc Chimera, Mouse, Recombinant
データシート
434-CT-200 RSDアールアンドディー システムス
R&D Systems, Inc.
200 μg ¥100,000
(未発注)
追加

在庫・価格 : 2024年05月02日 14時57分 現在

CTLA-4/Fc Chimera, Mouse, Recombinant

  • 商品コード:434-CT-200
  • メーカー:RSD
  • 包装:200μg
  • 価格: ¥100,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Vaughan AN et al. Porcine CTLA4-Ig lacks a MYPPPY motif, binds inefficiently to human B7 and specifically suppresses human CD4+ T cell responses costimulated by pig but not human B7. J. Immunol. 2000 Sep;165(6):3175-81
Vaughan AN et al
2000/01/01
Application: Binding Assay, Sample Type: Cell Supernates PubMed
2 Bonham CA et al. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J. Immunol. 2002 Sep;169(6):3382-91
Bonham CA et al
2002/01/01
Application: ELISA Standard PubMed
3 Attanavanich K et al. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J. Immunol. 2004 Jan;172(2):803-11
Attanavanich K et al
2004/01/01
Species: Mouse, Application: Bioassay, Sample type: Cell Supernates PubMed
4 Hausl C et al. Preventing restimulation of memory B cells in hemophilia A: a potential new strategy for the treatment of antibody-dependent immune disorders. Blood 2004 Jul;104(1):115-22
Hausl C et al
2004/01/01
Species: Mouse, Application: Bioassay, Sample type: Whole Cells PubMed
5 Mirenda V et al. Modified dendritic cells coexpressing self and allogeneic major histocompatability complex molecules: an efficient way to induce indirect pathway regulation. J. Am. Soc. Nephrol. 2004 Apr;15(4):987-97
Mirenda V et al
2004/01/01
Application: Bioassay PubMed
6 La Cava A et al. Ig-reactive CD4+CD25+ T cells from tolerized (New Zealand Black x New Zealand White)F1 mice suppress in vitro production of antibodies to DNA. J. Immunol. 2004 Sep;173(5):3542-8
La Cava A et al
2004/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
7 Anderson KM et al. Induction of CTLA-4-mediated anergy contributes to persistent colonization in the murine model of gastric Helicobacter pylori infection. J. Immunol. 2006 May;176(9):5306-13
Anderson KM et al
2006/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
8 Hanna J et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med. 2006 Sep;12(9):1065-74
Hanna J et al
2006/01/01
Species: Mouse, Application: Control PubMed
9 Feunou P et al. Foxp3+CD25+ T regulatory cells stimulate IFN-gamma-independent CD152-mediated activation of tryptophan catabolism that provides dendritic cells with immune regulatory activity in mice unresponsive to staphylococcal enterotoxin B. J. Immuno
Feunou P et al
2007/01/01
Species: Mouse, Application: Bioassay, Sample type: Whole Cells PubMed
10 Butte MJ et al. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 2007 Jul;27(1):111-22
Butte MJ et al
2007/01/01
Application: Bioassay PubMed
11 Orbach A et al. CTLA-4 . FasL induces early apoptosis of activated T cells by interfering with anti-apoptotic signals. J. Immunol. 2007 Dec;179(11):7287-94
Orbach A et al
2007/01/01
Species: Mouse, Application: Bioassay, Sample type: Whole Cells PubMed
12 Leitner J et al. TIM-3 does not act as a receptor for galectin-9. PLoS Pathog. 2013 Mar;9(3):e1003253
Leitner J et al
2013/01/01
Application: Bioassay, Sample Type: cell cultures PubMed
13 Kowalczyk A et al. Cell-extrinsic CTLA4-mediated regulation of dendritic cell maturation depends on STAT3. Eur. J. Immunol. 2014 Apr;44(4):1143-55
Kowalczyk A et al
2014/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
14 Peng Y et al. CD86 is an activation receptor for NK cell cytotoxicity against tumor cells. PLoS ONE 2013;8(12):e83913
Peng Y et al
2013/01/01
Application: In Vivo, Sample Type: In Vivo PubMed
15 Stojanovic A et al. CTLA-4 is expressed by activated mouse NK cells and inhibits NK Cell IFN-γ production in response to mature dendritic cells. J. Immunol. 2014 May;192(9):4184-91
Stojanovic A et al
2014/01/01
Application: Blocking, Sample Type: Whole Cells PubMed
16 Sandin LC et al. Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo. Oncoimmunology 2014 Jan;3(1):e27614
Sandin LC et al
2014/01/01
Application: Bioassay, Sample Type: Serum PubMed
17 Khan A et al. Dendritic cell modification as a route to inhibiting corneal graft rejection by the indirect pathway of allorecognition. Eur. J. Immunol. 2013 Mar;43(3):734-46
Khan A et al
2013/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
  • No.: 1
  • 文献情報:
    Vaughan AN et al. Porcine CTLA4-Ig lacks a MYPPPY motif, binds inefficiently to human B7 and specifically suppresses human CD4+ T cell responses costimulated by pig but not human B7. J. Immunol. 2000 Sep;165(6):3175-81
    Vaughan AN et al
    2000/01/01
  • 備考:
    Application: Binding Assay, Sample Type: Cell Supernates
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Bonham CA et al. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J. Immunol. 2002 Sep;169(6):3382-91
    Bonham CA et al
    2002/01/01
  • 備考:
    Application: ELISA Standard
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Attanavanich K et al. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J. Immunol. 2004 Jan;172(2):803-11
    Attanavanich K et al
    2004/01/01
  • 備考:
    Species: Mouse, Application: Bioassay, Sample type: Cell Supernates
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Hausl C et al. Preventing restimulation of memory B cells in hemophilia A: a potential new strategy for the treatment of antibody-dependent immune disorders. Blood 2004 Jul;104(1):115-22
    Hausl C et al
    2004/01/01
  • 備考:
    Species: Mouse, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Mirenda V et al. Modified dendritic cells coexpressing self and allogeneic major histocompatability complex molecules: an efficient way to induce indirect pathway regulation. J. Am. Soc. Nephrol. 2004 Apr;15(4):987-97
    Mirenda V et al
    2004/01/01
  • 備考:
    Application: Bioassay
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    La Cava A et al. Ig-reactive CD4+CD25+ T cells from tolerized (New Zealand Black x New Zealand White)F1 mice suppress in vitro production of antibodies to DNA. J. Immunol. 2004 Sep;173(5):3542-8
    La Cava A et al
    2004/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Anderson KM et al. Induction of CTLA-4-mediated anergy contributes to persistent colonization in the murine model of gastric Helicobacter pylori infection. J. Immunol. 2006 May;176(9):5306-13
    Anderson KM et al
    2006/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Hanna J et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med. 2006 Sep;12(9):1065-74
    Hanna J et al
    2006/01/01
  • 備考:
    Species: Mouse, Application: Control
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Feunou P et al. Foxp3+CD25+ T regulatory cells stimulate IFN-gamma-independent CD152-mediated activation of tryptophan catabolism that provides dendritic cells with immune regulatory activity in mice unresponsive to staphylococcal enterotoxin B. J. Immuno
    Feunou P et al
    2007/01/01
  • 備考:
    Species: Mouse, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Butte MJ et al. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 2007 Jul;27(1):111-22
    Butte MJ et al
    2007/01/01
  • 備考:
    Application: Bioassay
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Orbach A et al. CTLA-4 . FasL induces early apoptosis of activated T cells by interfering with anti-apoptotic signals. J. Immunol. 2007 Dec;179(11):7287-94
    Orbach A et al
    2007/01/01
  • 備考:
    Species: Mouse, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Leitner J et al. TIM-3 does not act as a receptor for galectin-9. PLoS Pathog. 2013 Mar;9(3):e1003253
    Leitner J et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: cell cultures
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Kowalczyk A et al. Cell-extrinsic CTLA4-mediated regulation of dendritic cell maturation depends on STAT3. Eur. J. Immunol. 2014 Apr;44(4):1143-55
    Kowalczyk A et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Peng Y et al. CD86 is an activation receptor for NK cell cytotoxicity against tumor cells. PLoS ONE 2013;8(12):e83913
    Peng Y et al
    2013/01/01
  • 備考:
    Application: In Vivo, Sample Type: In Vivo
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Stojanovic A et al. CTLA-4 is expressed by activated mouse NK cells and inhibits NK Cell IFN-γ production in response to mature dendritic cells. J. Immunol. 2014 May;192(9):4184-91
    Stojanovic A et al
    2014/01/01
  • 備考:
    Application: Blocking, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Sandin LC et al. Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo. Oncoimmunology 2014 Jan;3(1):e27614
    Sandin LC et al
    2014/01/01
  • 備考:
    Application: Bioassay, Sample Type: Serum
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Khan A et al. Dendritic cell modification as a route to inhibiting corneal graft rejection by the indirect pathway of allorecognition. Eur. J. Immunol. 2013 Mar;43(3):734-46
    Khan A et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed